American International Group, Inc. Trevena Inc Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.5 $16,238 - $40,596	-81,193 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.41 - $0.63 $2,342 - $3,599	-5,714 Reduced 6.57%	81,193 $45,000
Q4 2021 Feb 11, 2022	SELL	$0.57 - $1.29 $1,481 - $3,354	-2,600 Reduced 2.9%	86,907 $51,000
Q3 2021 Nov 12, 2021	SELL	$1.11 - $1.7 $2,360 - $3,615	-2,127 Reduced 2.32%	89,507 $110,000
Q2 2021 Aug 13, 2021	BUY	$1.46 - $2.25 $133,785 - $206,176	91,634 New	91,634 $155,000
Q2 2018 Aug 08, 2018	SELL	$1.44 - $2.24 $53,889 - $83,827	-37,423 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$1.51 - $2.06 $551 - $751	-365 Reduced 0.97%	37,423 $61,000
Q4 2017 Feb 09, 2018	BUY	$1.4 - $2.6 $1,479 - $2,748	1,057 Added 2.88%	37,788 $60,000
Q3 2017 Nov 09, 2017	BUY	$2.22 - $2.79 $81,542 - $102,479	36,731	36,731 $94,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.